1. Pilote L. Ramipril use in Canada: HOPE or HYPE?[editorial]. CMAJ 2003; 168 (5): 568-9.
2. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes …

… STAGE A At high risk for HF but without structural heart disease or symptoms of HF. … This
study provided hope that perhaps this slow regenerative capacity of the heart can be exploited …

… More than just hype s researchers involved in the Heart Outcomes Prevention Evaluation
(HOPE), we read with interest the article by Karen Tu and colleagues" and Louise Pilotc's …

… of developing a coronary heart disease, high risk people would probably be expected to
adopt certain measures that are known to prevent the development of this disease, such as diet, …

The 2019 annual meeting of the American Heart Association, which was held in Philadelphia,
was marked by considerable buzz around a presentation on the International Study of …

Early risk stratification in heart failure (HF) might improve clinical outcomes via providing
individualized treatment care. In this context, measuring plasma levels of cardiac biomarkers, ie …

… In some cases, we found that a referred patient's medical history and examination
findings weren't at all suggestive of significant coronary heart disease. The cardiology fellow …

… The recent creation of several mouse models that mimic aspects of human heart disease
represents an auspicious step toward the development of improved drug therapies. …

… Cardiovascular diseases (CVD) are the leading cause of disease burden globally, being the
… Ischemic heart disease and stroke account for a large proportion of these CVD deaths, 9.14 …

… heart disease and heart failure at the primary, secondary, and tertiary levels. The author
also suggests that Big Data and data mining may be ways of obtaining it, but is skeptical about …